It has been reported that the expression of SFN is frequently lost in various types of human diseases including ovarian cancer[45], uterine papillary serous carcinoma[46], uterine leiomyomas [47], ovarian granulosa cell tumors and steroid cell tumors[48]. This evidence concerns the gene SFN and uterine corpus leiomyoma.